When cystic fibrosis hits your lungs hard, hit back. Everything you need to know about getting your lungs back into shape is ...

Glox Therapeutics Ltd. has been awarded a share of a £3 million (US$3.7 million) collaborative discovery program launched by the Cystic Fibrosis Antimicrobial Resistance (CF AMR) syndicate. The ...

Patients aged 6 to 11 years with cystic fibrosis receiving 24-week once-daily vanzacaftor/tezacaftor/deutivacaftor generally ...

Cystic fibrosis is an illness best known for causing frequent lung infections and chronic breathing problems. However, it affects or­gans and tissues throughout the body, including the urogenital ...

I spent my childhood and young adulthood being told I was “too young and healthy” to be dealing with the health issues I experienced. But as an adult, I was determined to find answers, and eventually, ...

Cystic fibrosis (CF) is a genetic disorder that primarily affects the lungs and digestive system, leading to severe respiratory issues and increased susceptibility to infections. One of the ...

Cystic fibrosis (CF) is a genetic disorder that ... a bacterium that can cause persistent lung infections in patients. The presence of Achromobacter in the respiratory tract of individuals with ...

Cystic fibrosis, a genetic disease that attacks the lungs, affects roughly 1 in 3,000 people, and cystic fibrosis-related diabetes (CFRD) is its most common complication, a rare and unique type ...

Cystic fibrosis pulmonary disease is characterized by chronic and recurrent infection, airway inflammation, bronchiectasis and progressive obstructive lung physiology. Advances in the treatment of ...

NA: Not available. Cystic fibrosis (CF) pulmonary disease is characterized by chronic and recurrent infection, and airway inflammation. Colonization and chronic airway infection with bacterial ...